Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

unknown375%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
unknownnot_applicable

Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19

NCT04336462
unknownnot_applicable

Adjuvant Therapy for Severe COPD Patients in the Stable Phase by an Oxyhydrogen Generator With Nebulizer

NCT02850185
completednot_applicable

A Therapy for Improving Symptoms in Patients With Acute Exacerbations of COPD by Hydrogen-Oxygen Generator With Neburlizer.

NCT04000451
unknownnot_applicable

Adjuvant Therapy for Severe Asthma by an Oxyhydrogen Generator With Nebulizer

NCT02883582

Clinical Trials (4)

Showing 4 of 4 trials
NCT04336462Not Applicable

Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19

Unknown
NCT02850185Not Applicable

Adjuvant Therapy for Severe COPD Patients in the Stable Phase by an Oxyhydrogen Generator With Nebulizer

Unknown
NCT04000451Not Applicable

A Therapy for Improving Symptoms in Patients With Acute Exacerbations of COPD by Hydrogen-Oxygen Generator With Neburlizer.

Completed
NCT02883582Not Applicable

Adjuvant Therapy for Severe Asthma by an Oxyhydrogen Generator With Nebulizer

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4